Intellia Therapeutics Inc
NASDAQ:NTLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Intellia Therapeutics Inc
NASDAQ:NTLA
|
US |
|
Portillos Inc
NASDAQ:PTLO
|
US |
|
L
|
L & K Engineering Co Ltd
TWSE:6139
|
TW |
|
Pliant Therapeutics Inc
NASDAQ:PLRX
|
US |
|
A
|
Amerco
F:AUK
|
US |
|
China Three Gorges Renewables Group Co Ltd
SSE:600905
|
CN |
|
T
|
Tractor Supply Co
XBER:TR4
|
US |
|
Constellation Energy Corp
NASDAQ:CEG
|
US |
|
D
|
Dongfang Electric Corp Ltd
SSE:600875
|
CN |
|
Trustmark Corp
NASDAQ:TRMK
|
US |
|
E
|
Eni SpA
XBER:ENI
|
IT |
|
B
|
Bidvest Group Ltd
JSE:BVT
|
ZA |
|
Charter Communications Inc
NASDAQ:CHTR
|
US |
|
TTM Technologies Inc
NASDAQ:TTMI
|
US |
Shareholder Yield
Current shareholder yield for NTLA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NTLA Price
Intellia Therapeutics Inc
| Average Annual Return | -15.97% |
| Standard Deviation of Annual Returns | 68.11% |
| Max Drawdown | -96% |
| Market Capitalization | 1.6B USD |
| Shares Outstanding | 118 130 000 |
| Percentage of Shares Shorted | 36.77% |
